However, other high-risk neuroblastoma tumors do not harbor either MYCN amplification or mutations in other known tumor drivers, suggesting that perhaps epigenetic changes, such as DNA methylation, are involved in the tumorigenesis process. Here, MYCN is linked to neuroblastoma.